Healthcare | April 28, 2026
Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The FDA decision was based on results from the pivotal POETYK PsA-1 and POETYK PsA-2 Phase 3 trials
Gazyva/Gazyvaro outperformed placebo across all key and secondary endpoints
A final decision on the updated application is expected in the first half of 2026, while intravenous (IV) Saphnelo remains commercially available
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
The study found that nerandomilast effectively slowed lung function decline in patients, with discontinuation rates similar to placebo
Subscribe To Our Newsletter & Stay Updated
